SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-227760
Filing Date
2012-05-11
Accepted
2012-05-11 13:16:33
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d326752d10q.htm 10-Q 536575
2 SECTION 302 CEO CERTIFICATION d326752dex311.htm EX-31.1 8464
3 SECTION 302 CFO CERTIFICATION d326752dex312.htm EX-31.2 8446
4 SECTION 906 CEO CERTIFICATION d326752dex321.htm EX-32.1 3113
5 SECTION 906 CFO CERTIFICATION d326752dex322.htm EX-32.2 2698
  Complete submission text file 0001193125-12-227760.txt   1719799

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clvs-20120331.xml EX-101.INS 170253
7 XBRL TAXONOMY EXTENSION SCHEMA clvs-20120331.xsd EX-101.SCH 12492
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20120331_cal.xml EX-101.CAL 27398
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20120331_lab.xml EX-101.LAB 101022
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20120331_pre.xml EX-101.PRE 60097
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 12833316
SIC: 2834 Pharmaceutical Preparations